Intel Corp. will help the Fund to work on a proposal for a study of $ 200 million of the technology used to provide care at home for the elderly, and Eric Dishman, an Intel fellow and Director of health innovationsaid in an interview.
The study will focus on the use of technology by 10 000 elderly people, said Dishman. Intel is looking for partners who can put funding for the proposal and the study and end a proposal describing the study of this year, he said.
In an effort of 5 to 10 years, researchers predict use sensors, computers connected to the Internet and other devices to capture data on daily activities of older persons, such that when they take the medicine and the speed with which they move on the House. The goal is to prove that the technology can follow physical and cognitive decline and understand how technology can help improve care providers for older persons in the settings of the home, hospitals and other facilities where care costs have skyrocketed in recent years. The so-called technology of aging on the spot market is expected to surge. Income comprehensive monitoring in patients with diseases such as diabetes and heart arrhythmia should increase to 16.6 billion in 2015, $ 11 billion last year, according to the Swedish consultant Berg Insight.
"There are likely to be more seniors which need you assistance at home," Andre Malm, senior analyst at the Berg, said in an interview. "It is a way to improve the quality of life for patients who want to live at home." What is needed, it is good, independent research "to prove that technologies to home work." The number of Americans aged 65 years or more will be increased to 72.1 million by 2030, 39.6 million in 2009, according to the Administration on aging.
One goal is to prove that technologies at home can be useful for early detection of diseases, and alert as grave emergency care providers, said Dishman. "I am certain that we will find ways to increase the prevention of falls and reduce depression," he said. Computers could remind consumers with Alzheimer's disease, for example, what they discussed in a previous conversation. A door can notify a caregiver that a person who has not gone outside for four days.
"You can solve a problem earlier, before becoming a clinical," Paul Crawford, Research Director of health for Intel Labs product, said in an interview. "Intel tries to make a living in the digital age." It's analog age now. "Crawford and Jeff Kaye, Professor at the University of Oregon Health & Science, are leading the work on the proposal. The study should be administered by the Foundation for the National Institutes of Health.
The study can begin as early as 2012, if additional funds are secure, Dishman said. His study SILvR (Senior independent living research) Initiative could cost 200 million dollars over 10 years and eventually followed some 10,000 households with seniors, he said. The exact cost of the study will be determined this year.
Potential donors of the work of proposal include the Robert Wood Johnson Foundation and the National Science Foundation, said Dishman. Robert Wood Johnson Foundation, which provides funding for public health projects, is "intrigued by the idea", Paul Tarini, senior officer of the Foundation programme, said in an interview. The Organization spoke with Intel on the study and is currently awaiting a funding proposal.
Intel makes chips and software used in home care. The company and GE Corp. formed a joint venture focused on technologies for independent living and telehealth in August.
Intel invested in technologies for 12 years senior health care, funding more than 100 University Grants, said Dishman.
Once the proposal is completed by the end of the year, Intel will push us and the European Union authorities to fund the study, said Dishman. Intel also spoke with representatives of the White House, including federal Chief Technology Officer Aneesh Chopra and shoot the study becoming an issue in the presidential election in 2012, he said.
"It is too expensive even for Intel alone produce clinical and financial evidence that these technologies detect diseases and reduce costs," said Dishman. "Even competitors need to meet and co-invest."
View the original article here
